Part 2: Myelodysplastic syndromes – classification systems

This publication has 21 references indexed in Scilit:

• Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
  Cancer, 2011
• Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
  Haematologica, 2011
• Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
  Haematologica, 2010
• Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes
  Leukemia Research, 2010
• The changing classification of myelodysplastic syndromes: what’s in a name?
  Hematology-American Society Hematology Education Program, 2009
• Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification‐Based Prognostic Scoring System (WPSS) and comparison with IPSS
  European Journal of Haematology, 2008
• Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
  Cancer, 2008
• A prognostic score for patients with lower risk myelodysplastic syndrome
  Leukemia, 2007
• Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications
  Leukemia Research, 2004
• Proposals for the classification of the myelodysplastic syndromes
  British Journal of Haematology, 1982